Reply  by Roberts, Peter F. et al.
Specific indications for the operation
were as follows:
1. Presence of thymoma (n  20) or
suspected thymic mass (n  3) on
the thoracic computed tomographic
or nuclear magnetic resonance scan
2. High titers of acetylcholine receptor
antibody (n  3)
3. Resistance to pyridostigmine ther-
apy or relapse after steroid or immu-
nosuppressive therapy (n  1)
4. Dependance on a high dosage of cor-
ticosteroids (n  2).
Our mortality rate was nil, and no major
morbidity was experienced. That is com-
mon to most of the surgical teams skilled in
the treatment of myasthenic patients and
makes the thymectomy a generally consid-
ered safe procedure.
The neurologic results of thymectomy
in our overall series of 45 patients with
OMG have been recently reported.6 The
remission rate was significantly higher in
patients with stage I myasthenia than in
those in the other Osserman categories.
In the more recent series of 29 patients,
the neurologic postoperative results were
22 complete remissions, 3 remissions with
medication, 3 cases of improved status, and
1 case of unchanged status.
Our experience, general considerations,
and results suggest that extended thymec-
tomy might play a role in highly selected
patients with OMG, and there is need for
further studies to assess its efficacy.
We again congratulate the authors, who
have focused and debated on what is con-
sidered a highly controversial indication
for thymectomy.
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Reply to the Editor:
We appreciate the comments by Lucchi
and colleagues at the University of Pisa.
Their results are consistent with ours, but
they differ in one important respect. In their
group of 29 patients, 23 were operated on
because of thymomas or suspected thymic
masses, and 3 had thymectomies because
nonoperative therapy had been ineffective
or was not tolerated. This suggests that
only 3 of their 29 patients had thymecto-
mies specifically for the treatment of ocular
myasthenia gravis (OMG), whereas OMG
was the indication for operation in all of
our patients. Our findings, supported by
those of Lucchi and associates and the Uni-
versity of Pennsylvania group,1 strongly
suggest that thymectomy achieves greater
remission rates for OMG than for more
advanced forms of myasthenia gravis. Thus
we recommend operation as the primary
treatment for OMG when the diagnosis is
firm.
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Percutaneous valve insertion: A new
approach?
To the Editor:
The recently published article on percuta-
neous aortic valve replacement Lutter and
associates1 strengthens our belief that non-
surgical valve replacement will soon be-
come a reality in the replacement of semi-
lunar cardiac valves.
Andersen, Knudsen, and Hasenkam2 re-
ported a nonsurgical heart valve replace-
ment as early as 1992, and this was fol-
lowed by similar attempts by other groups.
Many technical problems have been en-
countered. The size of the vascular access
required was too big, the function of the
valve after compression and re-expansion
could be compromised, and finally the
newly implanted valve could obstruct the
coronary orifices in aortic implantations.
We reported our first experimental studies
in 2000 for percutaneous pulmonary valve
replacement and, after ethical approval, the
first human heart valve implantation was
performed by us in September 2000.3,4. In
parallel, we reported our first successful
aortic implantations in an experimental
setup without creating coronary obstruction
due to a newly designed stent with a two-
step deployment strategy.5 In April 2002,
the French newspapers reported the first
successful percutaneous implantation of an
aortic valve as an emergency procedure in
a 47-year-old man in cardiogenic shock.
This came as a result of an ongoing re-
search project by Alain Cribier in Rouen,
France.
The article by Lutter and associates re-
ports their experience with aortic implan-
tations. As in our early aortic work, they
have experimented with valve implanta-
tions in the supracoronary position. In this
position, the valve implant does not ob-
struct the coronary orifices and the pressure
difference over the closed valve is signifi-
cantly smaller. This decreases the force to
dislodge the valve after implantation and
leads to reduced stress on the functioning
valve leaflets. In our experience, implanta-
tion in this position was technically easy.
However, in contrast to Lutter and cowork-
ers, we had significant problems with cor-
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